Myocyte death in the failing human heart is gender dependent

Circulation Research

Volumn 85, Issue 9, 1999, Pages 856-866

  Guerra, Sabrina ^a   Leri, Annarosa ^a   Wang, Xiaowei ^a   Finato, Nicoletta ^b   Di Loreto, Carla ^b   Beltrami, Carlo Alberto ^b   Kajstura, Jan ^a   Anversa, Piero ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

Apoptosis; Cardiomyopathy; Heart failure; Necrosis; Sex

Indexed keywords

APOPTOSIS; ARTICLE; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DNA CLEAVAGE; DNA DAMAGE; ELECTRON MICROSCOPY; FEMALE; HEART FAILURE; HEART MUSCLE CELL; HUMAN; HUMAN CELL; MALE; MOLECULAR PROBE; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 0032724201     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.85.9.856     Document Type: Article

References (42)

1. Isles CG, Hole DJ, Hawthorne VM, Lever AF. Relation between coronary risk and coronary mortality in women of the Renfew and Paisley survey: comparison with men. Lancet. 1992;339:702-706.
2. Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio T, Barrett-Connor E. Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Circulation. 1997;96:2468-2482.
3. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med. 1993; 328:1069-1075.
4. Von Eiff AW, Goglin E, Jacobs U, Neus H. Ambulatory blood pressure in children followed for 3 years: influence of sex and family history on hypertension. Clin Exp Hypertens. 1986;8:577-581.
5. Narula J, Haider N, Virmani R, Disalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw B-A. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 1996;335: 1182-1189.
6. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P. Apoptosis in the failing human heart. N Engl J Med. 1997;336: 1131-1141.
7. Li Z, Bing OHL, Long X, Robinson KG, Lakatta EG. Increased cardiomyocyte apoptosis during the transition of heart failure in the spontaneously hypertensive rat. Am J Physiol. 1997;272: H2313-H2319.
8. Cheng W, Kajstura J, Nitahara JA, Li B, Reiss K, Liu Y, Clark WA, Krajewski S, Reed JC, Olivetti G, Anversa P. Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res. 1996;226:316-327.
9. Li Q, Li B, Wang X, Leri A, Jana KP, Liu Y, Kajstura J, Baserga R, Anversa P. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest. 1997;100: 1991-1999.
10. Goussev A, Sharov VG, Shimoyama H, Tanimura M, Lesch M, Goldstein S, Sabbah HN. Effects of ACE inhibition on cardiomyocyte apoptosis in dogs with heart failure. Am J Physiol. 1998;275: H626-H631.
11. Benjamin IJ, Jalil JE, Tan LB, Cho K, Weber KT, Clark WA. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res. 1989;65:657-670.
12. Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, Reed JC, Olivetti G, Anversa P. Apoptotic and necrotic myocyte cell death are independent contributing variables of infarct size in rats. Lab Invest. 1996;74:86-107.
13. Olivetti G, Giordano G, Corradi D, Melissari M, Lagrasta C, Gambert SR, Anversa P. Gender differences and aging: effects in the human heart. J Am Coll Cardiol. 1995;26:1068-1079.
14. Didenko VV, Hornsby PJ. Presence of double-strand breaks with single-base 3′ overhangs in cells undergoing apoptosis but not necrosis. J Cell Biol. 1996;135:1369-1376.
15. Li B, Setoguchi M, Wang X, Andreoli AM, Leri A, Malhotra A, Kajstura J, Anversa P. Insulin-like growth factor-1 attenuates the detrimental impact of non-occlusive coronary artery constriction on the heart. Circ Res. 1999;84:1007-1019.
16. Leri A, Claudio PP, Li Q, Wang X, Reiss K, Wang S, Malhotra A, Kajstura J, Anversa P. Strech-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2 to Bax protein ratio in the cell. J Clin Invest. 1998;101:1326-1342.
17. Leri A, Liu Y, Malhotra A, Li Q, Stiegler P, Claudio PP, Giordano A, Kajstura J, Hintze TH, Anversa P. Pacing-induced heart failure in dogs enhances the expression of p53 and p53-dependent genes in ventricular myocytes. Circulation. 1998;97:194-203.
18. Cusick ME, Wassarman PM, DePamphillis ML. Application of nucleases to visualizing chromatin organization at replication forks. Methods Enzymol. 1989;170:290-316.
19. Holzman E. Lysosomes. New York: Plenum Press; 1989.
20. Belkin AM, Zhidkova NI, Balzac F, Altruda F, Tomatis D, Maier A, Tarone G, Koteliansky VE, Burridge K. β1D integrin displaces the β1A isoform in striated muscles: localization at junctional structures and signalling potential in nonmuscle cells. J Cell Biol. 1996;132: 211-226.
21. Loud AV, Anversa P. Biology of disease: morphometric analysis of biologic processes. Lab Invest. 1984;50:250-261.
22. Deng G, Wu R. An improved procedure for utilizing terminal transferase to add homopolymers to the 3′ termini of DNA. Nucleic Acids Res. 1981;9:4173-4188.
23. Anversa P, Leri A, Beltrami CA, Guerra S, Kajstura J. Myocyte death and growth in the failing heart. Lab Invest. 1998;78:767-786.
24. Sharov VG, Sabbah HN, Shimoyama H, Goussev A, Lesch M, Goldstein S. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol. 1996;148:141-149.
25. Adams KF, Sueta CA, Gheorghiade M, O'Connor CM, Schwartz TA, Hoch GG, Uretsky B, Swedberg K, McKenna W, Soler-Soler J, Califf RM. Gender differences in survival in advanced heart failure: insights from the FIRST study. Circulation. 1999;99:1816-1821.
26. Richards RG, DiAugustine RP, Petrusz P, Clark GC, Sebastian J. Estradiol stimulates tyrosine phosphorylation of the insulin-like growth factor-1 receptor and insulin receptor substrate-1 in the uterus. Proc Natl Acad Sci USA. 1996;93:12002-12007.
27. Werner H, Adamo M, Roberts CT Jr, LeRoith D. Molecular and cellular aspects of insulin-like growth factor action. Vitam Horm. 1994;48:1-55.
28. Tonshoff B, Powell DR, Zhao D, Durham SK, Coleman ME, Domene HM, Blum WF, Baxter RC, Moore LC, Kaskel FJ. Decreased hepatic insulin-like growth factor (IGF)-I and increased IGF binding protein-1 and -2 gene expression in experimental uremia. Endocrinology 1997; 138:938-946.
29. Grohé C, Kahlert S, Löbbert K, Vetter H. Expression of oestrogen receptor αand β in rat heart: role of local oestrogen synthesis. J Endrocrinol. 1998;156:R1-R7.
30. Hickey GT, Krasnow JS, Beattle WG, Richards J. Aromatase cytochrome P450 in rat ovarian granulosa cells before and after luteinization: adenosine 3′, 5′-monophosph-dependent and independent regulation cloning and sequencing of rat aromatase cDNA and 5′ genomic DNA. Mol Endocrinol. 1990;4:3-12.
31. Greendale GA, Edelstein S, Barrett-Connor E. Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo study. J Bone Miner Res. 1997;12:1833-1843.
32. Grohé C, Kahlert S, Löbbert K, Stimpel M, Karas RH, Vetter H, Neyses L. Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Lett. 1997;107-112.
33. L. J Neurosurg. 1998;88:884-889.
34. Wang L, Ma W, Markovich R, Lee WL, Wang PH. Insulin-like growth factor 1 modulates induction of apoptotic signaling in H9C2 cardiac muscle cells. Endocrinology. 1998;139:1354-1364.
35. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. Akt phosphorylation of BAD couples survival signals to the cell: intrinsic death machinery. Cell. 1997;91:231-241.
36. Tsukahara H, Gordienko DV, Tonschoff B, Gelato MC, Goligorsky MS. Direct demonstration of insulin-like growth factor-1-induced nitric oxide production by endothelial cells. Kidney Int. 1994;45: 598-604.
37. Huang A, Sun D, Koller A, Kaley G. Gender difference in myogenic tone of rat arterioles is due to estrogen-induced, enhanced release of NO. Am J Phsyiol 1997;272:H1804-H1809.
38. Lefer AM, Lefer DJ. Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. Annu Rev Pharmacol Toxicol. 1993;33:71-90.
39. Kajstura J, Leri A, Finato N, Di Loreto C, Beltrami CA, Anversa P. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA. 1998;95:8801-8805.
40. Parodi O, De Maria R, Oltrona L, Testa R, Sarnbuceti G, Roghi A, Merli M, Belingheri L, Accinni R, Spinelli F, Pellegrini A, Baroldi G. Myocardial blood flow distribution in patients with ischemic heart disease of dilated cardiomyopathy undergoing heart transplantation. Circulation. 1993:88:509-522.
41. The SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement trial. N Engl J Med. 1992;327:669-677.
42. Buja LM, Entman ML. Modes of myocardial cell injury and cell death in ischemic heart disease. Circulation. 1998;98:1355-1357.